https://scholars.lib.ntu.edu.tw/handle/123456789/635104
標題: | The impact of comorbidities, neutrophil-to-lymphocyte ratio, and drug toxicities on quality of life in lung cancer patients receiving EGFR-TKI therapy | 作者: | Chen, Jung-Yueh SHENG-KAI LIANG Chuang, Tzu-Yi CHIA-YU CHU CHIA-HUNG TU Yeh, Yu-Jo Wei, Yu-Feng KUAN-YU CHEN |
關鍵字: | Adverse events; Comorbidity; Epidermal growth factor receptor tyrosine kinase inhibitor; Neutrophil-to-lymphocyte ratio; Non-small cell lung cancer; Quality of life | 公開日期: | 2024 | 卷: | 123 | 期: | 2 | 起(迄)頁: | 198 | 來源出版物: | Journal of the Formosan Medical Association = Taiwan yi zhi | 摘要: | Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are used as the standard first-line treatment for patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC). However, the impact of comorbidities and treatment toxicities on quality of life (QoL) was seldom investigated. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/635104 | ISSN: | 0929-6646 | DOI: | 10.1016/j.jfma.2023.07.017 |
顯示於: | 醫學院附設癌醫中心醫院(臺大癌醫) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。